Title : The Th1 chemokine MIG in Graves' Disease: a narrative review of the literature.

Pub. Date : 2019 Jul-Aug

PMID : 31304517






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Methimazole (MMI), used for the hyperthyroidism treatment, causes a reduction of the MIG secretion by isolated thyrocytes, a decrease of serum MIG levels and leads to a shift from a Th1 to Th2 response in patients with GD in the active phase. Methimazole C-X-C motif chemokine ligand 9 Homo sapiens
2 Methimazole (MMI), used for the hyperthyroidism treatment, causes a reduction of the MIG secretion by isolated thyrocytes, a decrease of serum MIG levels and leads to a shift from a Th1 to Th2 response in patients with GD in the active phase. Methimazole C-X-C motif chemokine ligand 9 Homo sapiens